- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LianBio ADR (LIANY)
LianBio ADR stock price live, this page displays OTC LIANY stock exchange data. View the LIANY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the LianBio ADR real time stock price chart below.
What Is the LianBio ADR Stock Price Today?
The LianBio ADR stock price today is 0.05.
What Is the Stock Symbol for LianBio ADR?
The stock symbol for LianBio ADR is ""LIANY.""
What Stock Exchange Does LianBio ADR Trade On?
LianBio ADR is listed and trades on the OTC Markets stock exchange.
Is LianBio ADR a Good Stock to Buy?
Determining whether LianBio ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIANY quote. (ISIN: US53000N1081)
What Is the LianBio ADR Stock Price Today?
The LianBio ADR stock price today is 0.05.
What Is the Stock Symbol for LianBio ADR?
The stock symbol for LianBio ADR is ""LIANY.""
What Stock Exchange Does LianBio ADR Trade On?
LianBio ADR is listed and trades on the OTC Markets stock exchange.
Is LianBio ADR a Good Stock to Buy?
Determining whether LianBio ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIANY quote. (ISIN: US53000N1081)
OTC Markets
Currency in USD
0.05
0.00(0.00%)
Closed·
Fair Value
An estimate of a LianBio ADR's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.05
0.05
52 wk Range
0.03
0.44
LIANY Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
Earnings results expected in 4 days
1/3
Fair Value
An estimate of a LianBio ADR's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.050.05
52 wk Range
0.030.44
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(756.97%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(756.97%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LIANY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a LianBio ADR's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- LianBio ADR receives Investment Bank Analyst Rating Update
- Investing.com
Pro - LianBio announces wind down and special dividend
- Investing.com
- LianBio announces wind down and special dividend
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
LianBio ADR Company Profile
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Crohn’s disease; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03 for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.
Compare LIANY to Peers and Sector
Metrics to compare | LIANY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIANYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −3.3x | −0.5x | |
PEG Ratio | 0.00 | −0.06 | 0.00 | |
Price/Book | 0.0x | 2.0x | 2.6x | |
Price / LTM Sales | 0.0x | 9.7x | 3.3x | |
Upside (Analyst Target) | 0.0% | 210.4% | 43.4% | |
Fair Value Upside | Unlock | 4.9% | 7.1% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does LianBio ADR Trade On?
LianBio ADR is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for LianBio ADR?
The stock symbol for LianBio ADR is "LIANY."
What Is the LianBio ADR Market Cap?
As of today, LianBio ADR market cap is 5.73M.
What Is LianBio ADR's Earnings Per Share (TTM)?
The LianBio ADR EPS (TTM) is -0.82.
When Is the Next LianBio ADR Earnings Date?
LianBio ADR will release its next earnings report on 11 Aug 2025.
From a Technical Analysis Perspective, Is LIANY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has LianBio ADR Stock Split?
LianBio ADR has split 0 times.
How Many Employees Does LianBio ADR Have?
LianBio ADR has 163 employees.
What is the current trading status of LianBio ADR (LIANY)?
As of 08 Aug 2025, LianBio ADR (LIANY) is trading at a price of 0.05, with a previous close of 0.05. The stock has fluctuated within a day range of 0.05 to 0.05, while its 52-week range spans from 0.03 to 0.44.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.